The ATR-CHEK1 checkpoint pathway is essential for buffering the high replication stress brought on by oncogenic KRAS mutations in PDAC, which enables tumor cells to survive despite severe DNA damage and replication fork instability [244,245]. Here, CHEK1 is linked to neoplasm.